AstraZeneca Goes All In On AL Amyloidosis With Caelum Acquisition

Deal Could Be Worth Up To $500m

 
• By Kevin Grogan
  
Alexion AZ
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business